MiR-183 functions as an oncogene by targeting ABCA1 in colon cancer

Da-Peng Bi1, Cheng-Hua Yin1, Xiao-Yue Zhang1

  • 1The Second Department of Internal Medicine, Jinan Second People's Hospital, Jinan, Shandong 250001, P.R. China.

Oncology Reports
|March 4, 2016
PubMed

Insights

Colon cancer progression is linked to aberrant ABCA1 expression. MicroRNA-183 (miR-183) promotes colon cancer growth by downregulating ABCA1, inhibiting apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Colon cancer is a leading cause of cancer mortality, with current therapies failing to eradicate all cancer cells.
  • Understanding the molecular mechanisms driving colon cancer pathogenesis is crucial for developing effective therapeutic strategies.
  • Aberrant expression of ATP-binding cassette transporter A1 (ABCA1) has been observed in colon cancer tissues.

Purpose of the Study:

  • To investigate the role of ABCA1 in colon cancer proliferation and apoptosis.
  • To identify microRNAs (miRNAs) that regulate ABCA1 expression in colon cancer.
  • To elucidate the functional impact of miR-183 on colon cancer cell behavior.

Main Methods:

  • Confirmation of ABCA1 aberrant expression in colon cancer.
  • Assessment of ABCA1's effect on colon cancer cell proliferation and apoptosis (HCT116 and LDL1 cell lines).
  • Bioinformatic prediction (miRanda) and experimental validation of miRNA targeting ABCA1 mRNA.
  • Analysis of miR-183's impact on colon cancer cell proliferation and apoptosis.

Main Results:

  • ABCA1 overexpression inhibited colon cancer cell proliferation, while ABCA1 silencing promoted proliferation and inhibited apoptosis.
  • miR-183 was identified as a miRNA targeting the 3'UTR of ABCA1 mRNA.
  • miR-183 was confirmed to degrade ABCA1 mRNA in colon cancer cells.
  • miR-183 overexpression promoted colon cancer cell proliferation and inhibited apoptosis.

Conclusions:

  • ABCA1 plays a tumor-suppressive role in colon cancer.
  • miR-183 acts as an oncogenic miRNA in colon cancer by downregulating ABCA1.
  • The miR-183/ABCA1 axis represents a potential therapeutic target for colon cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K